249 related articles for article (PubMed ID: 33740630)
1. Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020.
Leren TP; Bogsrud MP
Atherosclerosis; 2021 Apr; 322():61-66. PubMed ID: 33740630
[TBL] [Abstract][Full Text] [Related]
2. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W
Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia.
Sjouke B; Yahya R; Tanck MWT; Defesche JC; de Graaf J; Wiegman A; Kastelein JJP; Mulder MT; Hovingh GK; Roeters van Lennep JE
J Clin Lipidol; 2017; 11(2):507-514. PubMed ID: 28502508
[TBL] [Abstract][Full Text] [Related]
4. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
5. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M
J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942
[TBL] [Abstract][Full Text] [Related]
7. LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population.
Yang KC; Su YN; Shew JY; Yang KY; Tseng WK; Wu CC; Lee YT
J Formos Med Assoc; 2007 Oct; 106(10):799-807. PubMed ID: 17964958
[TBL] [Abstract][Full Text] [Related]
8. Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease.
Sjouke B; Defesche JC; Hartgers ML; Wiegman A; Roeters van Lennep JE; Kastelein JJ; Hovingh GK
J Clin Lipidol; 2016; 10(6):1462-1469. PubMed ID: 27919364
[TBL] [Abstract][Full Text] [Related]
9. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R; Bozon D; Belabbas K; MBou F; Girardet JP; Tounian P; Jolly M; Boccara F; Cohen A; Karsenty A; Dubern B; Carel JC; Azar-Kolakez A; Feillet F; Labarthe F; Gorsky AM; Horovitz A; Tamarindi C; Kieffer P; Lienhardt A; Lascols O; Di Filippo M; Dufernez F
J Lipid Res; 2016 Mar; 57(3):482-91. PubMed ID: 26802169
[TBL] [Abstract][Full Text] [Related]
10. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia.
Defesche JC; Stefanutti C; Langslet G; Hopkins PN; Seiz W; Baccara-Dinet MT; Hamon SC; Banerjee P; Kastelein JJP
J Clin Lipidol; 2017; 11(6):1338-1346.e7. PubMed ID: 28964736
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
Di Taranto MD; D'Agostino MN; Fortunato G
Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
[TBL] [Abstract][Full Text] [Related]
13. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
Sjouke B; Kusters DM; Kindt I; Besseling J; Defesche JC; Sijbrands EJ; Roeters van Lennep JE; Stalenhoef AF; Wiegman A; de Graaf J; Fouchier SW; Kastelein JJ; Hovingh GK
Eur Heart J; 2015 Mar; 36(9):560-5. PubMed ID: 24585268
[TBL] [Abstract][Full Text] [Related]
14. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
[TBL] [Abstract][Full Text] [Related]
15. APOE p.Leu167del mutation in familial hypercholesterolemia.
Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
[TBL] [Abstract][Full Text] [Related]
16. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.
van der Graaf A; Avis HJ; Kusters DM; Vissers MN; Hutten BA; Defesche JC; Huijgen R; Fouchier SW; Wijburg FA; Kastelein JJ; Wiegman A
Circulation; 2011 Mar; 123(11):1167-73. PubMed ID: 21382890
[TBL] [Abstract][Full Text] [Related]
20. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.
Bertolini S; Calandra S; Arca M; Averna M; Catapano AL; Tarugi P;
Atherosclerosis; 2020 Nov; 312():72-78. PubMed ID: 32977124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
